News and Opinions

By Michael Irving - New Atlas Scientists at Stanford Medicine have tested a new potential treatment for Alzheimer’s disease in mice. The therapy involves transplanting blood stem cells from healthy mice into those with the disease, which helps replace defective neural...

San Francisco, CA, September 28, 2023 — The Healthspan Action Coalition commemorates International Longevity Day, October 1 and Longevity Month, October, as a day of activism promoting healthy aging through a live rally and walk from San Francisco’s Ferry Building to...

By inside Precision Medicine A new method of genome manipulation can rapidly engineer RNA viruses through precise cleavage and repair, with potential applications for antiviral therapeutics, vaccines, and screening of mutations. The new recombinant technology enables...

By St. Jude Children's Research Hospital Scientists at St. Jude found that a subset of CD8+ T cells in the brain lessens the activation of microglia and limits disease pathology in a model of Alzheimer’s disease. As many as 5.8 million Americans are currently living...

By Lizzy Lawrence - Stat The artificial womb, a device aiming to save infants born way too soon, is inching closer to being tested in humans. The technology is close enough to reality that the Food and Drug Administration has decided to convene a two-day panel...

By Stanford University School of Engineering - SciTech Daily When an injury occurs in many organisms, a whole-body response is triggered, possibly aiding in healing and regeneration; this is seen in mice, axolotls, zebrafish, and planarian worms. In planarians,...

By Kelley Luckstein - Mayo Clinic  ROCHESTER, Minn. — Survival outcomes using chimeric antigen receptor-T cell therapy (CAR-T cell therapy) continue to be impressive for patients with some blood cancers. “Five years ago, the survival rate for people with blood cancers...

Noelle Alviz-Gransee - Des Moines Register Iowa Attorney General Brenna Bird sued two businesses and their owners for allegedly selling fraudulent stem cell therapy treatments to more than 250 Iowans. The lawsuit filed against Biologics Health LLC, Summit Partners...

By Taylor Mixides - Drug Target Review Scientists at Stanford University have engineered a biomolecule that can specifically remove mucins from cancer cells. This breakthrough could have a significant impact on future cancer therapies. Cancer cells can elude the...

By Lynda De Widt - Mayo Clinic Growing up in Nigeria, Dr. Zubair had high ambitions, including dreams of becoming an astronaut. Though he has not taken flight, his work has – literally. In 2017, several samples of donated stem cells from Dr. Zubair's lab were on...

By NASA NASA and its international partners approved the crew for Axiom Space’s third private astronaut mission to the International Space Station, launching from the agency’s Kennedy Space Center in Florida no earlier than January 2024. Axiom Space’s chief astronaut...

By Clay Risen and Amanda Holpuch - The New York Times Ian Wilmut, the British scientist who led the project that cloned a mammal for the first time, Dolly the sheep, shocking scientists who had thought that such a procedure was impossible, died on Sunday. He was 79....

by Live Science Scientists have transformed cancer cells into healthy muscle tissue in the lab using CRISPR gene-editing technology — and they hope new cancer treatments can be built on the back of this experiment. In a study published Aug. 28 in the journal PNAS,...

by Ann Megdell - Michigan Medicine A study from the University of Michigan Department of Neurosurgery and Rogel Cancer Center shows promising early results that a therapy combining cell-killing and immune-stimulating drugs are safe and effective in extending survival...

by Technology Networks News A single injection of a novel CRISPR gene-editing treatment safely and efficiently removes SIV – a virus related to the AIDS-causing agent HIV – from the genomes of non-human primates, scientists at the Lewis Katz School of Medicine at...

by University of Edinburgh A world-renowned embryologist and specialist in regenerative medicine, Sir Ian led the team that cloned Dolly the Sheep in 1996 – the first mammal to be cloned from an adult cell. Some 27 years on, the breakthrough continues to fuel many of...

by Genetic Engineering & Biotechnology News A research team headed by investigators at Brigham and Women’s Hospital reported on the results of a study in which they used stem cells from Alzheimer’s disease (AD) patients to identify a potential mechanism by which a...

By Paul Sisson - The San Diego Tribune A newly announced $5 million donation to UC San Diego that will support a new gene therapy initiative illustrates the value of making good on big promises. The contribution is the latest from philanthropists Nancy and Jeff Stack...